Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
M OhtaI J Sarfeh

Abstract

Anti-tumor necrosis factor alpha (TNF-alpha) treatment decreases nitric oxide (NO) synthesis and ameliorates the hyperdynamic circulation in portal hypertensive rats. We have recently demonstrated that nitric oxide synthase isoform 3 (NOS3) is overexpressed in portal hypertensive gastric mucosa and that resultant NO overproduction probably is responsible for the increased susceptibility of the mucosa to damage. In the present study, we examined whether TNF-alpha is overexpressed in portal hypertensive gastric mucosa and whether anti-TNF-alpha treatment affects gastric NOS3 messenger RNA (mRNA) and protein expression. We examined plasma concentrations of TNF-alpha and its protein expression in gastric specimens from portal hypertensive and sham-operated rats using Western blotting and immunohistochemistry. We also measured gastric mucosal blood flow, gastric expression of NOS3 mRNA and protein, and NOS3 enzyme activity in rats with and without TNF-alpha-neutralizing antibody treatment. The TNF-alpha protein levels in portal hypertensive stomachs were significantly increased by 57% compared with levels in sham-operated controls. TNF-alpha antibody treatment normalized gastric mucosal blood flow in portal hypertensive stomachs and...Continue Reading

References

Jan 1, 1992·Annual Review of Immunology·P Vassalli
Jul 1, 1992·Gastroenterology·H TilgC Huber
Nov 8, 1985·Science·L J Old
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M Fràter-SchröderP Böhlen
Jan 1, 1985·Gastroenterology·G M AndersonD J Cohen
Mar 31, 1989·Journal of Immunological Methods·N SuzukiM Fujino
Jun 1, 1988·The American Review of Respiratory Disease·K E StephensT A Raffin
Nov 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A S TarnawskiH Gergely
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J R GambleM A Vadas
Mar 25, 1983·Nucleic Acids Research·U NudelD Yaffe
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·C J EdgellJ B Graham
Aug 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P A CahillJ V Sitzmann
Apr 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A Diez-RuizD Fuchs
Dec 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M OhtaK Sugimachi
Mar 1, 1996·Infection·H M HasselhornF W Tiller
Apr 1, 1997·Gastroenterology·A T Axon

❮ Previous
Next ❯

Citations

Feb 3, 2011·Hepatology International·Gurbakhshish Singh SidhuKartar Singh
Jul 16, 1999·Journal of Hepatology·P SogniD Lebrec
Feb 8, 2006·Journal of Gastroenterology and Hepatology·Seiichiro KaiSeigo Kitano
Feb 5, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hirofumi KawanakaAndrzej S Tarnawski
Apr 12, 2006·European Journal of Gastroenterology & Hepatology·Mohammed A KarajehDermot C Gleeson
Feb 6, 2007·Journal of the Chinese Medical Association : JCMA·Hui-Chun HuangShou-Dong Lee
Apr 23, 2015·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Jung-Ta KaoYi-Ying Wu
Dec 13, 2006·Clinics in Liver Disease·Richard Moreau, Didier Lebrec
Nov 22, 2007·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Seiichiro KaiSeigo Kitano
Jan 6, 2007·Histopathology·A Srivastava, G Y Lauwers
Nov 22, 2005·Journal of Hepatology·Daniel A Langer, Vijay H Shah
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H KawanakaA S Tarnawski
Oct 4, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kouji TsugawaAndrzej S Tarnawski
Apr 23, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tomohiko AkahoshiMichael K Jones
Apr 27, 2000·Endocrine Reviews·J P HinsonD M Smith
Apr 14, 2019·Clinical Journal of Gastroenterology·Botros Shenoda, Joseph Boselli
Mar 9, 2005·World Journal of Gastroenterology : WJG·Zhao-Hui YinShu-Ping Ren

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.